ELI LILLY & Co Accounts Receivable 2008-2026 | LLY
Beta
What is accounts receivable?
Accounts receivable represents money owed to the company by customers for goods or services already delivered but not yet paid for.
What is ELI LILLY & Co's current accounts receivable?
ELI LILLY & Co (LLY) annual accounts receivable for 2025 was $17.76B, a 61.37% increase from 2024. ELI LILLY & Co accounts receivable for the quarter ending March 31, 2026 was $18.43B.
What was ELI LILLY & Co's accounts receivable in 2024?
ELI LILLY & Co annual accounts receivable for 2024 was $11.01B, a 21.07% increase from 2023.
What was ELI LILLY & Co's accounts receivable in 2023?
ELI LILLY & Co annual accounts receivable for 2023 was $9.09B, a 31.82% increase from 2022.
What is ELI LILLY & Co's 5-year accounts receivable CAGR?
ELI LILLY & Co accounts receivable grew at a compound annual growth rate (CAGR) of 24.76% from FY2020 to FY2025, going from $5.88B to $17.76B over 5 years.
Accounts Receivable History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+24.8%
FY2020
$5.88B
→
FY2025
$17.76B
080910111213141516171819202122232425
5 years selected
Accounts Receivable History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $17.76B | +61.4% | 10-K |
| FY2024 | $11.01B | +21.1% | 10-K |
| FY2023 | $9.09B | +31.8% | 10-K |
| FY2022 | $6.90B | +3.3% | 10-K |
| FY2021 | $6.67B | +13.6% | 10-K |
| FY2020 | $5.88B | +29.2% | 10-K |
| FY2019 | $4.55B | -1.0% | 10-K |
| FY2018 | $4.59B | +1.0% | 10-K |
| FY2017 | $4.55B | +12.8% | 10-K |
| FY2016 | $4.03B | +14.7% | 10-K |
| FY2015 | $3.51B | +8.6% | 10-K |
| FY2014 | $3.23B | -5.8% | 10-K |
| FY2013 | $3.43B | +2.9% | 10-K |
| FY2012 | $3.34B | -7.3% | 10-K |
| FY2011 | $3.60B | +3.0% | 10-K |
| FY2010 | $3.49B | +4.5% | 10-K |
| FY2009 | $3.34B | +20.3% | 10-K |
| FY2008 | $2.78B | - | 10-K |
Company: ELI LILLY & CoTicker: LLYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →